Urogenital Diseases: News and Research on Urination Disorders

MeSH tree: C12.050.351.968.934

FDA approves Empaveli for rare kidney diseases

The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals' Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).

New technology monitors bladder dysfunction in patients

Dr. Jason Kim and Dr. Steven Weissbart of the Women's Pelvic Health and Continence Center at Stony Brook University Hospital (SBUH) have successfully performed one of the nation's first—and the East Coast's very first—Glean ...

page 4 from 18